A venture capital firm has appointed a computer algorithm to its board of directors.
The program - called Vital - will vote on whether to invest in a specific company or not.
The firm it will be working for - Deep Knowledge Ventures - focuses on drugs for age-related diseases.
It said that Vital would make its recommendations by sifting through large amounts of data.
The algorithm looks at a range of data when making decisions - including financial information, clinical trials for particular drugs, intellectual property owned by the firm and previous funding.
Source and more information: BBC News